Moderna Inc at TD Cowen Healthcare Conference Transcript

Mar 03, 2026 / 06:50PM GMT
Release Date Price: CHF38.71 (-6.04%)
Tyler Van Buren
TD Cowen - Analyst

Good afternoon, everyone. Tyler Van Buren here, senior biotech analyst at TD Cowen. Thank you very much for joining TD Cowen's 46th Annual Healthcare Conference.

For this next session, it's a privilege to be hosting a fireside chat with Moderna management. And from Moderna, it's my pleasure to introduce Jamey Mock, Chief Financial Officer of Moderna.

Jamey, so great to have you. Thank you for joining me.

James Mock
Moderna Inc - Chief Financial Officer

Thanks for having us, Tyler.

Questions & Answers

Tyler Van Buren
TD Cowen - Analyst

So we'll start at a high level before we get into some of the more detailed programs or specific programs. But for the full-year 2025 product revenue came in at the high end of the guidance, which I think surprised some given the COVID normalization concerns and macro factors throughout the year and volatility on that front.

But maybe you could just talk about what drove the resilience of the COVID franchise

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot